Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.12 USD | +2.17% | -0.28% | -19.85% |
06-02 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
06-02 | GSK blood cancer drug nearly halves risk of death in late-stage trial | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.85% | 83.29B | |
+40.73% | 739B | |
+31.06% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.96% | 240B | |
+9.46% | 210B | |
-5.15% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb Names Christopher Boerner as Chair